Drugs / Sodium Gualenate
Sodium Gualenate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05808010 | Jun 2023 → Apr 2025 | chronic atrophic gastritis | Shandong Provincial Hospital | Unknown | No outcome recorded |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Gualenate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05808010 ↗ |
| Known as | Azulene sn | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Azunol st | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Guaiazulene 3-sulfonate sodium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Gualenate de sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Gualenato de sodio | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Oristar sgs | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Sodium guaiazulene sulfonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Sodium guaiazulene-3-sulfonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Sodium guaiazulene-3-sulphonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Sodium guaiazulenesulphonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Known as | Soluble guaiazulene | ChEMBL registry synonym — accepted as the source's own label CHEMBL1852533 ↗ |
| Modality | Small molecule | — CHEMBL1852533 ↗ |